Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Amphastar Pharmaceuticals...

    NASDAQ: AMPH · Real-Time Price · USD
    24.66
    0.10 (0.41%)
    At close: Jun 23, 2025, 3:31 PM

    Amphastar Pharmaceuticals Statistics

    Share Statistics

    Amphastar Pharmaceuticals has 47.14M shares outstanding. The number of shares has increased by -2.56% in one year.

    Shares Outstanding

    n/a
    		 47.14M

    Shares Change (YoY)

    n/a
    		 -2.56%

    Shares Change (QoQ)

    n/a
    		 -0.9%

    Owned by Institutions (%)

    n/a
    		 72.84%

    Shares Floating

    n/a
    		 34.78M

    Failed to Deliver (FTD) Shares

    n/a
    		 182

    FTD / Avg. Volume

    n/a
    		 0.03%

    Short Selling Information

    The latest short interest is 4.1M, so 8.69% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 4.1M

    Short % of Shares Out

    n/a
    		 8.69%

    Short % of Float

    n/a
    		 17.22%

    Short Ratio (days to cover)

    n/a
    		 9

    Valuation Ratios

    The PE ratio is 11.27 and the forward PE ratio is 7.22. Amphastar Pharmaceuticals's PEG ratio is 0.73.

    PE Ratio

    n/a
    		 11.27

    Forward PE

    n/a
    		 7.22

    PS Ratio

    n/a
    		 2.52

    Forward PS

    n/a
    		 1.3

    PB Ratio

    n/a
    		 2.46

    P/FCF Ratio

    n/a
    		 10.43

    PEG Ratio

    n/a
    		 0.73
    Financial Ratio History

    Enterprise Valuation

    Amphastar Pharmaceuticals has an Enterprise Value (EV) of 2.3B.

    EV / Sales

    n/a
    		 3.22

    EV / EBITDA

    n/a
    		 8.28

    EV / EBIT

    n/a
    		 10.77

    EV / FCF

    n/a
    		 13.33

    Financial Position

    The company has a current ratio of 3.07, with a Debt / Equity ratio of 0.89.

    Current Ratio

    n/a
    		 3.07

    Quick Ratio

    n/a
    		 2.19

    Debt / Equity

    n/a
    		 0.89

    Debt / EBITDA

    n/a
    		 2.35

    Debt / FCF

    n/a
    		 3.77

    Interest Coverage

    n/a
    		 6.77

    Financial Efficiency

    Return on Equity is 21.78% and Return on Invested Capital is 12.28%.

    Return on Equity

    n/a
    		 21.78%

    Return on Assets

    n/a
    		 10.11%

    Return on Invested Capital

    n/a
    		 12.28%

    Revenue Per Employee

    n/a
    		 $351,486.19

    Profits Per Employee

    n/a
    		 $78,658.28

    Employee Count

    n/a
    		 2,028

    Asset Turnover

    n/a
    		 0.45

    Inventory Turnover

    n/a
    		 2.2

    Taxes

    Income Tax

    n/a
    		 29.67M

    Effective Tax Rate

    n/a
    		 15.64%

    Stock Price Statistics

    The stock price has increased by -39.43% in the last 52 weeks. The beta is 0.76, so Amphastar Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.76

    52-Week Price Change

    n/a
    		 -39.43%

    50-Day Moving Average

    n/a
    		 24.76

    200-Day Moving Average

    n/a
    		 35.93

    Relative Strength Index (RSI)

    n/a
    		 42.37

    Average Volume (20 Days)

    n/a
    		 582,024

    Income Statement

    In the last 12 months, Amphastar Pharmaceuticals had revenue of 712.81M and earned 159.52M in profits. Earnings per share was 3.29.

    Revenue

    n/a
    		 712.81M

    Gross Profit

    n/a
    		 373.86M

    Operating Income

    n/a
    		 205.42M

    Net Income

    n/a
    		 159.52M

    EBITDA

    n/a
    		 277.31M

    EBIT

    n/a
    		 220.11M

    Earnings Per Share (EPS)

    n/a
    		 3.29
    Full Income Statement

    Balance Sheet

    The company has 151.61M in cash and 650.55M in debt, giving a net cash position of -498.94M.

    Cash & Cash Equivalents

    n/a
    		 151.61M

    Total Debt

    n/a
    		 650.55M

    Net Cash

    n/a
    		 -498.94M

    Retained Earnings

    n/a
    		 568.79M

    Total Assets

    n/a
    		 1.63B

    Working Capital

    n/a
    		 388.91M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 213.39M and capital expenditures -41.04M, giving a free cash flow of 172.34M.

    Operating Cash Flow

    n/a
    		 213.39M

    Capital Expenditures

    n/a
    		 -41.04M

    Free Cash Flow

    n/a
    		 172.34M

    FCF Per Share

    n/a
    		 3.56
    Full Cash Flow Statement

    Margins

    Gross margin is 52.45%, with operating and profit margins of 28.82% and 22.38%.

    Gross Margin

    n/a
    		 52.45%

    Operating Margin

    n/a
    		 28.82%

    Pretax Margin

    n/a
    		 26.62%

    Profit Margin

    n/a
    		 22.38%

    EBITDA Margin

    n/a
    		 38.9%

    EBIT Margin

    n/a
    		 28.82%

    FCF Margin

    n/a
    		 24.18%

    Dividends & Yields

    AMPH does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 8.87%

    FCF Yield

    n/a
    		 9.58%
    Dividend Details

    Analyst Forecast

    The average price target for AMPH is $32, which is 30.6% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $32

    Price Target Difference

    n/a
    		 30.6%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $82.25

    Lynch Upside

    n/a
    		 235.71%

    Graham Number

    n/a
    		 33.48

    Graham Upside

    n/a
    		 36.65%

    Scores

    Altman Z-Score

    n/a
    		 2.48

    Piotroski F-Score

    n/a
    		 7

    Add to Watchlist